Skip to content
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
  • Contact
  • Subscribe
  • Insights Newsletter

    Always Be a Step Ahead

    Learn the important healthcare trends that could affect you in advance. Get expert analysis and discover the innovative ideas that are helping businesses overcome today's challenges.

    Subscribe to AMI's Insights Newsletter Today.

     

  • Login
Access Market IntelligenceAccess Market Intelligence
  • Menu
  • About
    • Dr. Randy Vogenberg
    • John Santilli
    • News Announcements
    • Contact
  • Shop Reports
    • Filter By
      • Discounted
      • Latest Releases
    • Report Topic or Type
      • Ebooks
      • Provider Trends
      • Payor Trends
      • Purchaser Trends
      • Market Access & Distribution
  • Solutions
    • Data and Intelligence Platforms
      • Employer Sales Initiatives
    • Advisory and Consulting Services
      • Virtual Advisory Board for Healthcare
      • Strategy Development
      • Health Benefit Training
      • Custom Market Research
    • Specialty Pharmacy Database
  • Resources
    • Insights Blog
    • Sample Reports
    • Free Publications
  • Specialty Pharmacy Database
    • Blog – Specialty Pharmacy
    • SPD Case Study
    • SPD Request for Information
  • $0.00 0
    • No products in the cart.

  • Shop
  • 0

    Cart

    No products in the cart.

Tag Archives: PFIC

Specialty Drug, Specialty Pharmacy

QOL Medical Selects Optum Frontier Therapies as New Partner for Sucraid®

Posted on April 18, 2022 by John Santilli
18
Apr

QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution

Continue reading →
Posted in Specialty Drug, Specialty Pharmacy  |  Tagged Albireo, Bylvay, Congenital Sucrase-Isomaltase Deficiency, CSID, enzyme replacement, Optum, Optum Frontier Therapies, PFIC, pharmacy partner, QOL Medical, rare disease, rare disorder, sacrosidase, Sucraid®, sucrose intolerance, US Bioservices
Rare/Orphan Disease, Specialty Pharmacy

Optum Frontier Therapies Selected by Albireo as a Limited Pharmacy Partner for Bylvay

Posted on August 3, 2021 by John Santilli

Optum® Frontier Therapies, a specialty pharmacy dedicated to people with rare disease, was founded to optimize every aspect of advanced therapeutics, from the point of prescribing to treatment and beyond

Continue reading →
Posted in Rare/Orphan Disease, Specialty Pharmacy  |  Tagged ACHC, Albireo, Bylvay, Center for Gene Therapy, Center for Rare Disease, chronic disease, Diplomat, disese, Distinction in Rare Diseases and Orphan Drugs, EnvoyHealth, liver disease, Optum, Optum Frontier Therapies, Optum Rx, orphan disease, PFIC, progressive familial intrahepatic cholestasis, rare disease

Copyright 2023 © Access Market Intelligence. All Rights Reserved  |  Terms of Service 

  • Login
  • Home
  • Reports
    • View Samples
    • What’s New
    • On Sale
    • eBooks
    • By Market
      • Payor
      • Purchaser
      • Provider
      • Market Access & Distribution
  • Services
    • Virtual Advisory Board
    • Strategy Development
    • Health Benefit Training
    • Market Research
  • Data Solutions
    • Specialty Pharmacy Database (SPD)
    • Employer Sales Initiatives
  • Resources
    • Blog
    • Free Downloads
  • About
    • Contact

Login

Lost your password?

Register